LRMR Larimar Therapeutics, Inc.
Nasdaq · SEC CIK 1374690 · EDGAR
- Bought, last 12 months
- $25.72M 5 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 68 since 2021-07-02, latest 2026-07-08 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | $25.00M | — |
| Hamilton Thomas Edward | Dir | $666.9K | — |
| THOMAS FRANK E | Dir | $25.0K | — |
| SHERMAN JEFFREY W | Dir | $25.0K | — |
| Shankar Gopi | Chief Development Off | — | — |
| Clayton Russell | Chief Medical Off | — | — |
| BEN-MAIMON CAROLE | Pres, CEO, Dir | — | — |
| Celano Michael | CFO | — | — |
Transactions 33
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-08 16:05 | 2026-07-06 | LRMR | Hamilton Thomas Edward | Dir | P - Purchase | $3.34 | +50.0K | 714.8K | +8% | +$166.9K | |
| MI | 2026-03-02 | 2026-02-27 | LRMR | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $5.00 | +5.00M | 10.62M | +89% | +$25.00M |
| 2026-03-02 | 2026-02-27 | LRMR | THOMAS FRANK E | Dir | P - Purchase | $5.00 | +5,000 | 7,000 | +250% | +$25.0K | |
| 2026-03-02 | 2026-02-27 | LRMR | SHERMAN JEFFREY W | Dir | P - Purchase | $5.00 | +5,000 | 5,000 | New | +$25.0K | |
| 2026-03-02 | 2026-02-27 | LRMR | Hamilton Thomas Edward | Dir | P - Purchase | $5.00 | +100.0K | 664.8K | +18% | +$500.0K | |
| D | 2026-01-27 | 2026-01-26 | LRMR | Celano Michael | CFO | A - Grant | $0.00 | +37.6K | 215.8K | +21% | $0 |
| D | 2026-01-27 | 2026-01-26 | LRMR | Shankar Gopi | Chief Development Off | A - Grant | $0.00 | +25.6K | 76.4K | +50% | $0 |
| D | 2026-01-27 | 2026-01-26 | LRMR | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +100.1K | 368.3K | +37% | $0 |
| D | 2026-01-27 | 2026-01-26 | LRMR | Clayton Russell | Chief Medical Off | A - Grant | $0.00 | +25.6K | 71.4K | +56% | $0 |
| MI | 2025-08-04 | 2025-07-31 | LRMR | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $3.20 | +9.38M | 7.32M | New | +$30.00M |
| D | 2025-01-24 | 2025-01-22 | LRMR | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +91.0K | 387.2K | +31% | $0 |
| D | 2025-01-24 | 2025-01-22 | LRMR | Clayton Russell | Chief Medical Off | A - Grant | $0.00 | +23.3K | 45.8K | +104% | $0 |
| D | 2025-01-24 | 2025-01-22 | LRMR | Shankar Gopi | Chief Development Off | A - Grant | $0.00 | +23.3K | 50.8K | +85% | $0 |
| D | 2025-01-24 | 2025-01-22 | LRMR | Celano Michael | CFO | A - Grant | $0.00 | +34.2K | 178.2K | +24% | $0 |
| D | 2024-05-31 | 2024-02-16 | LRMR | Hamilton Thomas Edward | Dir | P - Purchase | $8.74 | +57.2K | 564.8K | +11% | +$500.0K |
| MI | 2024-02-16 | 2024-02-16 | LRMR | Deerfield Mgmt L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $8.74 | +4.29M | 4.21M | New | +$37.50M |
| 2024-02-15 | 2024-02-14 | LRMR | THOMAS FRANK E | Dir | P - Purchase | $11.00 | +2,000 | 2,000 | New | +$22.0K | |
| D | 2024-01-19 | 2024-01-17 | LRMR | Celano Michael | CFO | A - Grant | $0.00 | +31.2K | 144.0K | +28% | $0 |
| D | 2024-01-19 | 2024-01-17 | LRMR | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +66.1K | 333.0K | +25% | $0 |
| D | 2024-01-19 | 2024-01-17 | LRMR | Clayton Russell | Chief Medical Off | A - Grant | $0.00 | +22.5K | 22.5K | New | $0 |
| D | 2024-01-19 | 2024-01-17 | LRMR | Shankar Gopi | Chief Development Off | A - Grant | $0.00 | +22.5K | 27.5K | +450% | $0 |
| 2023-12-08 | 2023-12-07 | LRMR | Shankar Gopi | Chief Development Off | P - Purchase | $3.73 | +5,000 | 5,000 | New | +$18.6K | |
| 2023-05-18 | 2023-05-17 | LRMR | Celano Michael | CFO | P - Purchase | $3.73 | +5,000 | 112.7K | +5% | +$18.6K | |
| 2023-05-18 | 2023-05-17 | LRMR | BEN-MAIMON CAROLE | Pres, CEO, Dir | P - Purchase | $3.71 | +5,000 | 266.8K | +2% | +$18.6K | |
| 2023-05-18 | 2023-05-17 | LRMR | Truitt Joseph | Dir | P - Purchase | $3.73 | +2,750 | 2,750 | New | +$10.3K | |
| D | 2023-02-02 | 2023-01-31 | LRMR | BEN-MAIMON CAROLE | Pres, CEO, Dir | A - Grant | $0.00 | +205.0K | 261.8K | +361% | $0 |
| D | 2023-02-02 | 2023-01-31 | LRMR | Celano Michael | CFO | A - Grant | $0.00 | +76.0K | 107.7K | +239% | $0 |
| MI | 2022-09-20 | 2022-09-16 | LRMR | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $3.15 | +11.11M | 2.78M | New | +$35.00M |
| 2022-09-20 | 2022-09-16 | LRMR | Hamilton Thomas Edward | Dir | P - Purchase | $3.15 | +317.5K | 507.6K | +167% | +$1000.0K | |
| 2022-09-19 | 2022-09-16 | LRMR | BEN-MAIMON CAROLE | Pres, CEO, Dir | P - Purchase | $3.15 | +31.7K | 56.8K | +127% | +$100.0K | |
| 2022-09-19 | 2022-09-16 | LRMR | Celano Michael | CFO | P - Purchase | $3.15 | +31.7K | 31.7K | New | +$100.0K | |
| 2021-07-02 | 2021-06-30 | LRMR | Hamilton Thomas Edward | Dir | P - Purchase | $8.75 | +56.7K | 190.1K | +43% | +$496.2K | |
| MI | 2021-07-02 | 2021-06-30 | LRMR | Deerfield Mgmt IV, L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $8.75 | +685.7K | 1.94M | +55% | +$6.00M |
Purchase Sale Sale after option exercise All abbreviations